Managing Partners
Edward G. Fey, Ph.D. Managing Partner
Dr. Fey is one of the founders of Biomodels, and provides expertise in the areas of intellectual property and study design and evaluation. Dr. Fey was one of the scientific founders of Matritech, Inc., a publicly-traded, cancer diagnostic company. Prior to co-founding Biomodels, Dr. Fey also worked for Brigham and Women’s Hospital in the Office of Technology Transfer, assisting researchers in the area of sponsored research and licensing.
Dr. Fey received his Ph.D. in Biochemistry from the University College London, England and completed his Postdoctoral Research Fellowship at the Massachusetts Institute of Technology in the Department of Biology.
Stephen T. Sonis, D.M.D., D.M.Sc. Chief Medical Consultant
Dr. Sonis is a world-renowned expert in the clinical treatment and research of cancer regimen-related mucosal toxicities. His development of predictive animal models has enabled the investigation of the biological basis of mucositis and has assisted in the development of potential therapies. The results of his studies on the molecular and cellular pathogenesis of mucositis have established the basis of a mechanistic paradigm for mucosal injury, and have provided a number of treatment targets.
Dr. Sonis has obtained degrees from Tufts University and Harvard University and has studied tumor immunology at Oxford University. He holds appointments at the Harvard School of Dental Medicine (Professor of Oral Medicine, Department of Oral Medicine, Infection and Immunity), the Dana-Farber Cancer Institute (Chief, Division of Oral Medicine, Oral and Maxillofacial Surgery and Dentistry), and Brigham and Women’s Hospital (Senior Surgeon) in Boston, MA.
Brynmor A. Watkins, Ph.D. Director of Research
As Biomodels’ Director of Research, Dr. Watkins supervises and oversees all of Biomodels preclinical research activities. Dr. Watkins scientific expertise lies in the areas of cell biology, molecular biology, virology, proteomics and assay development.
Dr. Watkins received his Ph.D. in Cell Biology from the University of London, England. He was a Postdoctoral Fellow of the National Institute of Neurological Diseases at the National Institute of Health. Dr. Watkins served as a Visiting Scientist in the Laboratory of Tumor Cell Biology at the National Cancer Institute. Dr. Watkins was Associate Director of Research at Lexigen Pharmaceuticals, and Director of Research for Matritech prior to joining Biomodels.
Professional Staff
Gregory D. Lyng, Ph.D. Senior Scientist
Dr. Lyng designs and conducts preclinical research studies at Biomodels. Dr. Lyng’s scientific expertise lies in the areas of in vivo models of disease, particularly in models of inflammatory bowel disease and diseases of the central nervous system.
Dr. Lyng received his Ph.D. in Biomedical Sciences from the University at Albany School of Public Health and his B.S. in neuroscience from St. Lawrence University.
Jonathan A. Zombeck, Ph.D. Senior Scientist
Dr. Zombeck designs and conducts preclinical research studies at Biomodels focused on animal models of chemotherapy induced fatigue. His scientific expertise lies in the areas of behavioral neuroscience, the development of animal models, and behavioral pharmacology.
Dr. Zombeck received his Ph.D. in Neuroscience from the University of Illinois and his B.A. in Psychology from Albion College.
Dr. Zombeck has over 6 years of experience in behavioral experiments using both mice and rats. He has actively published in the field with peer reviewed articles in multiple journals including Neuroscience, Genes Brain and Behavior, and Psychopharmacology.
Advisors
Timothy J. Maher, Ph.D.
Dean of Research and Graduate Programs, Sawyer Professor of Pharmaceutical Sciences and Professor of Pharmacology at Massachusetts College of Pharmacy and Health Sciences
